Plasmapheresis for severe lipemia: Comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants

Journal of Clinical Apheresis

Volumn 18, Issue 1, 2003, Pages 32-36

  Yeh, Jiann Horng ^a   Lee, May Fen ^a   Chiu, Hou Chang ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chylomicron; Double filtration plasmapheresis; Plasma exchange; Removal rate; Triglyceride

Indexed keywords

ACIPIMOX; ATORVASTATIN; CHOLESTEROL; ETOFIBRATE; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD FILTRATION; BLOOD FLOW; CHOLESTEROL BLOOD LEVEL; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMOLYSIS; HUMAN; HYPERTRIGLYCERIDEMIA; INCIDENCE; MALE; PLASMAPHERESIS; PRESSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTILIPEMIC AGENTS; CHOLESTEROL; FEMALE; FILTRATION; HEMOLYSIS; HUMANS; HYPERLIPIDEMIAS; KINETICS; LIPIDS; MALE; MIDDLE AGED; PANCREATITIS; PLASMA EXCHANGE; PLASMAPHERESIS; TRIGLYCERIDES;

EID: 0038077187     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10047     Document Type: Article

References (18)

1. Thompson GR, Miller JP, Breslow JL. Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. Br Med J 1985;291:1671-1673.
2. Thompson GR, Maher VMG, Mattews S, Kitano Y, Neuwieth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, de Feyter P, Henderson A. Familial hypercholesterolemia regression study: a randomized trial of low-density-lipoprotein apheresis. Lancet 1995;345:811-816.
3. Kroon AA, Aengevaeren WM, van der Werf T, Uijen GH, Reiber JC, Bruschke AG, Stalenhoef AH. LDL-apheresis atherosclerosis regression study (LAARS): effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93:1826-1835.
4. Bosch T, Lennertz A, Kordes B, Samtleben W. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center. Ther Apheresis 1999;3:209-213.
5. Richter WO, Jacob BG, Ritter MM, Suhler K, Vierneisel K, Schwandt P. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 1993;42:888-894.
6. Lane DM, McConathy WJ, Laughlin LO, Comp PC, von Albertini B, Gibson SM, Bricker LA, Kozlovskis P, Dorrier C. Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J Cardiol 1993;71:816-822.
7. Matsuda Y, Malchesky PS, Nosé Y. Low-density lipoprotein removal methods by membranes and future perspectives. Artificial Organs 1996;20:346-355.
8. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-1210.
9. Piolot A, Nadler F, Cavallero E, Coquard J, Jacotot B. Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 1996;13:96-99.
10. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Int Med 1991;37:249-273.
11. Homma Y, Mikami Y, Tamachi H, Nakaya N, Nakamura H, Goto Y. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis, and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia. Metabolism 1987;36:419-425.
12. Suzuki M, Yamane S, Matsugane T, Nobuto T, Azuma N, Nishide T, Shinomiya M, Saito K, Sasaki N, Nosé Y. Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients. Artificial Organs 1996;20:296-302.
13. Sueoka A. Present status of apheresis technologies: part 1. membrane plasma separator. Therapeutic Apheresis 1996;1:42-48.
14. Ginsberg HN, Goldberg IJ. Disorders of lipoprotein metabolism. In: Braunwald E, Fauci AS, Isselbacher KJ, et al, editors. Harrison's Principles of Internal Medicine. 14th ed. New York: McGraw-Hill; 1998. p 2138-2149.
15. Lennertz A, Parhofer KG, Samtleben W, Bosch T. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apheresis 1999;3:227-233.
16. Agishi T, Kaneko I, Hasuo Y, Hayasaka Y, Sanaka T, Ota K, Amemiya H, Sugino N, Abe M, Ono T, Kawai S, Yamane T. Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs 1980;26:406-409.
17. Yeh JH, Chiu HC. Double filtration plasmapheresis in myasthenia gravis-analysis of clinical efficacy and prognostic parameters. Acta Neurol Scand 1999;100:305-309.
18. Schmaldienst S, Banyai S, Stulnig TM, Heinz G, Jansen M, Horl WH, Derfler K. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia. Atherosclerosis 2000;151:493-499.